Clinical Utility of the Collect Scale to Assess Comorbidities in Patients With Chronic Lymphocytic Leukemia

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.1632
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Comorbidities Predict Inferior Outcomes in Chronic Lymphocytic Leukemia Treated With Ibrutinib

Cancer
Cancer ResearchOncology
2018English

Making Clinical Trials Work for Older Patients With Chronic Lymphocytic Leukemia

Journal of Geriatric Oncology
GerontologyGeriatricsOncology
2020English

Management of Patients With Chronic Lymphocytic Leukemia Treated With Lenalidomide

Clinical Journal of Oncology Nursing
Oncology
2010English

Circulating VE-cadherin in Patients With Controlled Chronic Lymphocytic Leukemia

Pathologia
2014English

Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Impacts of Zanubrutinib on Immune Cells in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Cost-Utility of Idelalisib in Combination With Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Clinical Pathways in Chronic Lymphocytic Leukemia: Challenges and Solutions

American Journal of Hematology
Hematology
2016English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy